3Daughters IUD

About 3Daughters

3Daughters is a private, preclinical-stage biotech company developing a disruptive, integrated uterine drug delivery system starting with a next-generation IUD. Its core innovation is a frameless, non-hormonal IUD composed of three magnetic copper ellipses that self-assemble in the uterus, paired with a patented Slider™ inserter/retriever system designed to reduce insertion pain and eliminate removal strings. The company is targeting the large and growing U.S. IUD market, with plans to file an IND and initiate Phase 1 trials in 2025, supported by a current Series A fundraising round of $15M.

Therapeutic Areas

Other Contraception Drugs